Medical Xpress·3 min read·medium
Photoswitch drug shows early signs of restoring light sensitivity in severely damaged retinas in first human trial
U
University of Adelaide
✦AI Summary
Researchers have successfully tested a new 'photoswitch' drug in humans that restores light sensitivity in patients with retinitis pigmentosa. This non-genetic approach offers a potential new treatment path for various forms of degenerative blindness.
Why it matters
This breakthrough could provide a simpler, more versatile treatment for blindness compared to current gene-based therapies.
edited by Lisa Lock , reviewed by Robert Egan
sciencehealth
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The report is a straightforward summary of scientific findings and clinical trial results.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in